Not ranked on the transparency index. Ro's pages blocked our reads on October 15, November 8, November 20 and November 21, 2026, so we cannot score it on current pages. Below is what Ro printed on September 17, 2026, a year of arithmetic from those prices, and the gaps we could not close. See the transparency index.

What is the Ro Body Program?

It is a brand-medication program. Ro charges a membership for the clinical service and passes through manufacturer self-pay prices for FDA-approved GLP-1s: the Wegovy pill, the Wegovy pen and the Zepbound KwikPen in our read. Ro offered no compounded GLP-1 when we last read its pricing page on September 17, 2026.

That model has one plain advantage, which is that you know what you are getting: a branded product with an FDA label. The trade-off is cost. Brand medication plus a membership costs more per month than the compounded programs in our price table.

What does Ro's pricing page say?

Ro Body Program terms as printed on ro.co/weight-loss/pricing, read September 17, 2026 (re-reads returned HTTP 403 on October 15 and November 8, 2026)
ItemWhat Ro printed
ModelMembership plus brand GLP-1s billed separately; no compounded GLP-1
Membership"$39 to start" (refunded if not eligible), then "$74–149/mo depending on the plan"; "$74/mo prepaid annually"
Wegovy pill$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)
Wegovy pen$199 (0.25 and 0.5 mg), $349 (1 to 2.4 mg), $399 (7.2 mg)
Zepbound KwikPen$299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg under the manufacturer's refill terms)
Billing basisMembership monthly or prepaid annually; medication per fill at self-pay prices (a Wegovy pen fill is four weekly doses)
Pharmacy disclosureNot recorded in our read
Prescriber or medical groupNot recorded in our read
Cancellation and refundsStart fee refunded if not eligible; other cancellation terms not recorded
Sourcero.co/weight-loss/pricing

Ro's medication ladder closely tracks the manufacturers' own self-pay offers. NovoCare, read November 8, 2026, lists the Wegovy pen at $349 for 0.25 to 2.4 mg with a $199 offer for two fills of 0.25 or 0.5 mg for new patients through December 31, 2026, and Wegovy HD 7.2 mg at $399.

What would 12 months on Ro cost?

Roughly $4,200 to $5,900 in our arithmetic, depending on the drug and how you pay the membership. These figures use only Ro's September 17, 2026 prices and the dose schedules in the FDA labels; your prescriber may move more slowly, which changes the totals.

12-month arithmetic from Ro's printed prices, read September 17, 2026; label escalation schedules; not a quote
ScenarioMedicationMembershipTotal (arithmetic)
Wegovy pill: one bottle each at 1.5, 4 and 9 mg, then nine at 25 mg$149 + $199 + $299 + 9 × $299 = $3,338Prepaid annual: 12 × $74 = $888$4,226
Wegovy pen: two fills at $199, then eleven at $349 (13 four-week fills = 52 weeks)$398 + $3,839 = $4,237Prepaid annual: $888$5,125
Same Wegovy pen schedule, monthly membership at the top tier$4,237$39 + 11 × $149 = $1,678$5,915

Ro's page did not say whether the $39 start fee is added to a prepaid annual plan; if it is, add $39 to the first two rows. The $199 Wegovy pen price is a new-patient offer that NovoCare says runs through December 31, 2026.

Pros and cons

Who should consider Ro, and who should look elsewhere?

Ro fits you if you want an FDA-approved brand drug, prefer per-dose prices you can check against the manufacturer, and are willing to pay for a managed program. The prepaid annual tier makes most sense if you expect to stay on treatment for a year.

Look elsewhere if your plan covers Wegovy or Zepbound through insurance, since a program that bills your insurer could cost less. If you are on Medicare Part D, check the Medicare GLP-1 Bridge first: a $50 copay for eligible enrollees from July 1, 2026 to December 31, 2027, covering Foundayo, Wegovy and the Zepbound KwikPen only. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge. Our Medicare Part D guide covers the rules.

What we could not verify

For label facts on the two main drugs, see our Wegovy and Zepbound pages. For a brand-to-brand view, read Hims vs Ro.

How it compares with NexLife

Ro prescribes FDA-approved brand drugs with a separate membership; NexLife prescribes compounded tirzepatide and semaglutide, which are not FDA-approved, at one price with no membership: $1,380 for a 12-month tirzepatide plan or $1,140 for semaglutide, as of November 6, 2026. NexLife is our editorial pick, while Ro is the route if a brand product matters to you. The figures side by side are in NexLife vs Ro.

Frequently asked questions

How much is the Ro Body Program membership?

On Ro's pricing page read September 17, 2026, the membership was $39 to start, refunded if you are not eligible, then $74 to $149 a month depending on the plan, with $74 a month as the prepaid annual rate. Medication was billed separately at self-pay prices. Ro blocked our October and November re-reads, so check the current tiers on ro.co.

Does Ro include the medication in its price?

No. Ro's membership covers the program, and the medication is a separate charge at self-pay prices. In our September 17, 2026 read, the Wegovy pill was $149 to $299 by dose, the Wegovy pen $199 to $399 and the Zepbound KwikPen $299 to $449. Add the membership to any of these to get your monthly figure.

Does Ro offer compounded semaglutide or tirzepatide?

Not in our September 17, 2026 read. Ro's pricing page listed only FDA-approved brand medications: the Wegovy pill, the Wegovy pen and the Zepbound KwikPen. If you want compounded medication, which is not FDA-approved, you would need a different program; if you want a brand product, Ro's per-dose pricing is one of the clearer ones we read.

What does a year of Wegovy through Ro cost?

As arithmetic from Ro's September 17, 2026 prices, a year of the Wegovy pill following the label's escalation comes to $3,338 in medication plus $888 for the prepaid annual membership, or $4,226. Thirteen four-week Wegovy pen fills come to $4,237 plus $888, or $5,125. Slower dose increases or price changes would alter these totals.

Can Medicare members use Ro for Wegovy or Zepbound?

We did not find Ro's Medicare terms in our read. Separately, the Medicare GLP-1 Bridge offers a $50 copay to eligible Part D enrollees from July 1, 2026 through December 31, 2027 for Foundayo, Wegovy and the Zepbound KwikPen, not vials. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge; their Part D plan might cover a GLP-1.

Sources

  1. Ro: weight loss pricing — read 2026-09-17; re-reads returned HTTP 403 on 2026-10-15 and 2026-11-08
  2. NovoCare: Wegovy savings offer and self-pay prices — pen, HD and pill prices and new-patient offer read 2026-11-08
  3. Lilly: LillyDirect Zepbound self-pay terms — prices and refill rules read 2026-10-15
  4. Medicare.gov: Weight-loss drug coverage (GLP-1 Bridge) — $50 copay, covered drugs and exclusions read 2026-11-08
  5. FDA label via DailyMed: Wegovy (semaglutide) prescribing information — label revised 6/2026; pen and tablet escalation schedules, read 2026-11-08

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.